Stage IA Breast Cancer Recruiting Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01750073Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Breast CancerTreatment